Prosight Management, LP Quant / Systematic

Location: Dallas, TX

CIK: 0001617201 · Show all filings

Period: Q4 2018 (← Previous) (Next →)

Filing Date: Feb 14, 2019

Total Value: $194M (100.0% shares, 0.0% debt)

Holdings (35)

— HANGER INC 11.6%

Value $22.54M Shares 1,189,399 Est. Cost $20.83 Unrealized —

— REATA PHARMACEUTICALS INC 7.3%

Value $14.19M Shares 253,000 Est. Cost $46.26 Unrealized —

CI CIGNA CORP NEW 7.2%

Value $13.92M Shares 73,300 Est. Cost $190.77 Unrealized 0.0%

— WELLCARE HEALTH PLANS INC 6.1%

Value $11.8M Shares 50,000 Est. Cost $236.10 Unrealized —

— ARENA PHARMACEUTICALS INC 5.6%

Value $10.81M Shares 277,650 Est. Cost $42.17 Unrealized —

ZBH ZIMMER BIOMET HLDGS INC 5.5%

Value $10.72M Shares 103,380 Est. Cost $109.70 Unrealized -3.3%

IOVA IOVANCE BIOTHERAPEUTICS INC 4.9%

Value $9.403M Shares 1,062,500 Est. Cost $11.58 Unrealized -16.7%

BMRN BIOMARIN PHARMACEUTICAL INC 4.5%

Value $8.77M Shares 103,000 Est. Cost $91.65 Unrealized +3.8%

— ALLERGAN PLC 4.2%

Value $8.207M Shares 61,400 Est. Cost $148.96 Unrealized —

— ALBIREO PHARMA INC 3.4%

Value $6.627M Shares 270,146 Est. Cost $29.61 Unrealized —

— ASSEMBLY BIOSCIENCES INC 3.2%

Value $6.242M Shares 275,941 Est. Cost $29.40 Unrealized —

GLPG GALAPAGOS NV 3.0%

Value $5.766M Shares 62,850 Est. Cost $91.74 Unrealized —

— INTEC PHARMA LTD JERUSALEM 2.6%

Value $5.098M Shares 676,104 Est. Cost $4.60 Unrealized —

— TELIGENT INC NEW 2.5%

Value $4.86M Shares 3,547,607 Est. Cost $3.21 Unrealized —

ASGN ASGN INC 2.5%

Value $4.78M Shares 87,700 Est. Cost $65.19 Unrealized 0.0%

VKTX VIKING THERAPEUTICS INC 2.5%

Value $4.774M Shares 624,000 Est. Cost $11.93 Unrealized +0.2%

— PROVIDENCE SVC CORP 2.4%

Value $4.699M Shares 78,298 Est. Cost $67.28 Unrealized —

KURA KURA ONCOLOGY INC 2.3%

Value $4.445M Shares 316,581 Est. Cost $16.20 Unrealized -18.2%

AXGN AXOGEN INC 2.2%

Value $4.272M Shares 209,088 Est. Cost $35.82 Unrealized -12.7%

— STRONGBRIDGE BIOPHARMA PLC 2.2%

Value $4.202M Shares 937,900 Est. Cost $4.65 Unrealized —

— CATALYST BIOSCIENCES INC 1.9%

Value $3.684M Shares 466,900 Est. Cost $9.35 Unrealized —

— SIERRA ONCOLOGY INC 1.7%

Value $3.371M Shares 2,553,943 Est. Cost $1.95 Unrealized —

ALDX ALDEYRA THERAPEUTICS INC 1.7%

Value $3.357M Shares 404,463 Est. Cost $10.25 Unrealized 0.0%

CNC CENTENE CORP DEL 1.5%

Value $2.883M Shares 25,000 Est. Cost $59.79 Unrealized +12.0%

MGNX MACROGENICS INC 1.3%

Value $2.465M Shares 194,129 Est. Cost $19.75 Unrealized -15.1%

EOLS EVOLUS INC 1.2%

Value $2.331M Shares 195,911 Est. Cost $19.50 Unrealized -26.9%

— MILLENDO THERAPEUTICS INC 1.1%

Value $2.041M Shares 256,739 Est. Cost $7.95 Unrealized —

LGND LIGAND PHARMACEUTICALS INC 0.9%

Value $1.71M Shares 12,600 Est. Cost $106.61 Unrealized 0.0%

— TRIPLE-S MGMT CORP 0.6%

Value $1.139M Shares 65,515 Est. Cost $17.39 Unrealized —

— CLOVIS ONCOLOGY INC 0.6%

Value $1.079M Shares 60,100 Est. Cost $17.95 Unrealized —

— CERECOR INC 0.5%

Value $994K Shares 307,733 Est. Cost $3.23 Unrealized —

— PIERIS PHARMACEUTICALS INC 0.5%

Value $885K Shares 332,846 Est. Cost $5.76 Unrealized —

— OPTINOSE INC 0.4%

Value $870K Shares 140,314 Est. Cost $6.20 Unrealized —

— CIDARA THERAPEUTICS INC 0.3%

Value $578K Shares 245,764 Est. Cost $6.80 Unrealized —

— AQUINOX PHARMACEUTICALS INC 0.1%

Value $173K Shares 80,289 Est. Cost $2.50 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	HANGER INC	1,189,399	$22.54M	11.6%	$20.83	—	COM NEW	41043F208
—	REATA PHARMACEUTICALS INC	253,000	$14.19M	7.3%	$46.26	—	CL A	75615P103
CI	CIGNA CORP NEW	73,300	$13.92M	7.2%	$190.77	0.0%	COM	125523100
—	WELLCARE HEALTH PLANS INC	50,000	$11.8M	6.1%	$236.10	—	COM	94946T106
—	ARENA PHARMACEUTICALS INC	277,650	$10.81M	5.6%	$42.17	—	COM NEW	040047607
ZBH	ZIMMER BIOMET HLDGS INC	103,380	$10.72M	5.5%	$109.70	-3.3%	COM	98956P102
IOVA	IOVANCE BIOTHERAPEUTICS INC	1,062,500	$9.403M	4.9%	$11.58	-16.7%	COM	462260100
BMRN	BIOMARIN PHARMACEUTICAL INC	103,000	$8.77M	4.5%	$91.65	+3.8%	COM	09061G101
—	ALLERGAN PLC	61,400	$8.207M	4.2%	$148.96	—	SHS	G0177J108
—	ALBIREO PHARMA INC	270,146	$6.627M	3.4%	$29.61	—	COM	01345P106
—	ASSEMBLY BIOSCIENCES INC	275,941	$6.242M	3.2%	$29.40	—	COM	045396108
GLPG	GALAPAGOS NV	62,850	$5.766M	3.0%	$91.74	—	SPON ADR	36315X101
—	INTEC PHARMA LTD JERUSALEM	676,104	$5.098M	2.6%	$4.60	—	SHS	M53644106
—	TELIGENT INC NEW	3,547,607	$4.86M	2.5%	$3.21	—	COM	87960W104
ASGN	ASGN INC	87,700	$4.78M	2.5%	$65.19	0.0%	COM	00191U102
VKTX	VIKING THERAPEUTICS INC	624,000	$4.774M	2.5%	$11.93	+0.2%	COM	92686J106
—	PROVIDENCE SVC CORP	78,298	$4.699M	2.4%	$67.28	—	COM	743815102
KURA	KURA ONCOLOGY INC	316,581	$4.445M	2.3%	$16.20	-18.2%	COM	50127T109
AXGN	AXOGEN INC	209,088	$4.272M	2.2%	$35.82	-12.7%	COM	05463X106
—	STRONGBRIDGE BIOPHARMA PLC	937,900	$4.202M	2.2%	$4.65	—	SHS USD	G85347105
—	CATALYST BIOSCIENCES INC	466,900	$3.684M	1.9%	$9.35	—	COM NEW	14888D208
—	SIERRA ONCOLOGY INC	2,553,943	$3.371M	1.7%	$1.95	—	COM	82640U107
ALDX	ALDEYRA THERAPEUTICS INC	404,463	$3.357M	1.7%	$10.25	0.0%	COM	01438T106
CNC	CENTENE CORP DEL	25,000	$2.883M	1.5%	$59.79	+12.0%	COM	15135B101
MGNX	MACROGENICS INC	194,129	$2.465M	1.3%	$19.75	-15.1%	COM	556099109
EOLS	EVOLUS INC	195,911	$2.331M	1.2%	$19.50	-26.9%	COM	30052C107
—	MILLENDO THERAPEUTICS INC	256,739	$2.041M	1.1%	$7.95	—	COM	60040X103
LGND	LIGAND PHARMACEUTICALS INC	12,600	$1.71M	0.9%	$106.61	0.0%	COM NEW	53220K504
—	TRIPLE-S MGMT CORP	65,515	$1.139M	0.6%	$17.39	—	CL B	896749108
—	CLOVIS ONCOLOGY INC	60,100	$1.079M	0.6%	$17.95	—	COM	189464100
—	CERECOR INC	307,733	$994K	0.5%	$3.23	—	COM	15671L109
—	PIERIS PHARMACEUTICALS INC	332,846	$885K	0.5%	$5.76	—	COM	720795103
—	OPTINOSE INC	140,314	$870K	0.4%	$6.20	—	COM	68404V100
—	CIDARA THERAPEUTICS INC	245,764	$578K	0.3%	$6.80	—	COM	171757107
—	AQUINOX PHARMACEUTICALS INC	80,289	$173K	0.1%	$2.50	—	COM	03842B101